Editorial: Benefit-risk factors associated with supplemental potassium therapy.
D003692:Delayed-Action Preparations; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006801:Humans; D007008:Hypokalemia / Q000188:drug therapy; D011189:Potassium Chloride / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D012306:Risk
D003692:Delayed-Action Preparations; D011189:Potassium Chloride